格隆汇9月30日丨清科控股(01945.HK)发布公告，2025年9月30日以2,636港元回购2,000股，回购价格每 股1.31-1.34港元。 ...

智通财经APP讯，清科控股(01945)发布公告，于2025年9月30日斥资2636港元回购2000股股份。 ...

表格類別： 股票 狀態： 新提交 公司名稱： 清科控股有限公司* 呈交日期： 2025年9月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01945 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註 ...

Core Insights - The Chinese venture capital market is experiencing a revival with a 12% year-on-year increase in fundraising, a 22% increase in investment quantity, and a 38% increase in IPO exits in the first half of 2025, driven by the AI wave and innovative pharmaceuticals [2] - The involvement of state-owned and industrial capital is more pronounced, leading to a shift in narrative and value judgment in the venture capital landscape [3] Group 1: Investment Strategies and Adjustments - Investment frequency has remained stable, with approximately 50 companies invested in annually, while focusing on self-incubation and international expansion [7] - Emphasis on hard technology, AI, advanced manufacturing, new materials, and healthcare, with a focus on maintaining organizational professionalism and market orientation [8] - The strategy has been to continue investing in core technology sectors while adapting to the increasing participation of state-owned and corporate venture capital [9][11] Group 2: Collaboration Over Competition - The current landscape is characterized by collaboration between government funds, corporate venture capital, and market-oriented institutions, rather than competition [11][13] - The government has transitioned from a role focused on attracting investment to becoming a key player in regional industrial development [12][14] - The market is expected to return to a more market-oriented approach in the long term, despite current structural fluctuations [13] Group 3: Future Opportunities in AI and Innovative Pharmaceuticals - The AI sector is seen as a significant opportunity, with investments in AI reaching 750 billion yuan in the first half of 2025, indicating a growing market despite existing gaps compared to the US [17][19] - The narrative around innovative pharmaceuticals is also evolving, with a notable increase in interest from international pharmaceutical companies in Chinese products [17][19] - The focus is on leveraging China's strengths in industrial applications and biomedicine, with a belief that persistence in investment will yield substantial returns in the future [19]

Core Viewpoint - Qingke Holdings (01945) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 1,600 shares at a total cost of 2,080 HKD [1] - The buyback price per share is set at 1.3 HKD [1] - The buyback is scheduled for September 29, 2025 [1]

Core Viewpoint - Qingke Holdings (01945) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Categories Company Actions - The company plans to repurchase 1,600 shares at a total cost of 2,080 HKD, translating to a buyback price of 1.3 HKD per share [1]

Group 1 - The company Qingke Holdings (01945.HK) announced a share buyback plan to repurchase 1,600 shares at a price of HKD 1.3 per share on September 29, 2025, totaling HKD 2,080 [1]

翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 清科控股有限公司* 呈交日期： 2025年9月29日 FF305 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01945 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

清科控股(01945)发布公告，该公司于2025年9月26日斥资2580港元回购2000股股份，每股回购价格为 1.29港元。 ...

Group 1 - The company, Qingke Holdings (01945.HK), announced a share buyback plan to repurchase 2,000 shares at a price of HKD 1.29 per share on September 26, 2025 [1] - The total amount for the buyback will be HKD 2,580 [1] - This buyback initiative reflects the company's strategy to enhance shareholder value [1]